Age4 yrs
Real estate1 parcel · 622 m²
Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of Infermia is 0.2% (very low). The 2025 annual accounts show equity of €20k and a net result of €12k. Equity is growing by ~100.1% per year across the filed fiscal years. Its solvency ranks better than 48% of 2219 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 3 annual accounts.
Signals
2 signals · with evidenceConsistently profitable
Positive net result in the two most recent financial years (2024 and 2025).
View the result trend Growing equity
Equity grew over 2023-2025. Profits are largely retained rather than distributed.
View the equity trend Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.
Filing behaviour
From the deposit records, complete market-wideLatest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 30-01-2026, 1 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
How we compute the deadline
The year end is derived from 3 filed financial years, each closing on 30-06. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 30-06-2025, that is 31-01-2026.
Deadline per financial year
| Year closed | Due by | Filed | Variance | Reference |
|---|---|---|---|---|
| 30-06-2025 | 31-01-2026 | 30-01-2026 | 1 d early | 2026-00021038 |
| 30-06-2024 | 31-01-2025 | 27-01-2025 | 4 d early | 2025-00010634 |
| 30-06-2023 | 31-01-2024 | 30-01-2024 | 1 d early | 2024-00012425 |
Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.
Trust signals
2 signalsMore than 3 years active
Founded in 2022, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.2%
Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector
−Young company
+Annual accounts: healthy financial profile
−
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Financials
TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€12k+144.6%
Working capital€14k+190.4%
Annual accounts & ratios
Source: NBB · 2025Annual accounts filed on 30-01-2026 with the NBB · fiscal year 2025 · micro
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing
Equity: growth of ~100.1%/year over 3 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (micro schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 55.7% | 58.2% | |
| Net result | €12k | €60k | |
| Equity | €20k | €74k | |
| Gross operating margin | €21k | €95k | |
| Total assets | €35k | €187k |
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
P48
Improving position over 2023-2025
· n=2219-6584
P15
Stable position over 2023-2025
· n=2217-6578
P27
Improving position over 2023-2025
· n=2219-6584
P11
Stable position over 2023-2025
· n=2219-6586
Describes the position versus peers, not a forecast.
€20k
+113.8%
23-25
€12k
+144.6%
23-25
€13k
+146.2%
23-25
€35k
+40.0%
23-25
€20k
+142.1%
23-25
€14k
+190.4%
23-25
€5k
+82.8%
23-25
€16k
-8.6%
23-25
Show 8 other metrics
€16k
-4.2%
23-25
1.90
+46.5%
23-25
1.90
+46.5%
23-25
55.7%
+72.9%
23-25
0.79
-62.2%
23-25
58.7%
+1.0%
23-25
32.7%
+74.7%
23-25
6.89
+30.4%
23-25
Figures by fiscal year
| Fiscal year | 2025 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €20k |
| Net profit | €12k |
| Cash flow | €13k |
| Staff costs | - |
| Income taxes | €5k |
| Dividends | - |
| Total assets | €35k |
| Equity | €20k |
| Debt | €16k |
| of which ≤ 1y | €16k |
| of which > 1y | - |
| Working capital | €14k |
| Employees (FTE) | - |
Ratios (computed)
| 2025 | |
|---|---|
| Current ratio | 1.90 |
| Quick ratio | 1.90 |
| Working capital ratio | 39.9% |
| Solvency | 55.7% |
| Debt / equity | 0.79 |
| Long-term debt ratio | - |
| Interest coverage | 6.89 |
| Gross margin | - |
| Net margin | - |
| ROA | 32.7% |
| ROE | 58.7% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Balance-sheet composition 2025
Full annual accounts (21 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €35k |
| Fixed assets | 21/28 | €6k |
| Tangible fixed assets | 22/27 | €6k |
| Current assets | 29/58 | €30k |
| Amounts receivable within one year | 40/41 | €18k |
| Cash & bank | 54/58 | €2k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €35k |
| Equity | 10/15 | €20k |
| Contributions / capital | 10/11 | €3k |
| Reserves | 13 | €17k |
| Amounts payable | 17/49 | €16k |
| Amounts payable within one year | 42/48 | €16k |
| Trade debts payable within one year | 44 | €4k |
| Income statement | ||
| Gross operating margin | 9900 | €21k |
| Operating result | 9901 | €19k |
| Financial income | 75 | €158 |
| Financial charges | 65 | €3k |
| Result before taxes | 9903 | €16k |
| Income taxes | 67/77 | €5k |
| Net result for the period | 9904 | €12k |
| Result to be appropriated | 9905 | €12k |
This table shows the latest fiscal year. 2 prior years, with figures and ratios, belong to a paid plan.
See plans →
Ratios computed by Checked.
Health barometer
FY 2025 · computed100
/ 100
Excellent
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Directors
Directors & mandates
1 director4 of this company's 4 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing below: a director who resigned there may therefore still show here as sitting. See the acts under Publications.
Former directors (1)
-
Tiziana MingollaDirectorState Gazette act 24075356 (15-05-2024)Former02-01-2024 → 16-06-2024
2 events
- 16-06-2024 Resigned· Director
- 02-01-2024 Appointed· Director
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.This list is read straight from this company's published acts, not from the officer register.
Insolvency mandates
No insolvency mandates (liquidators, administrators) on record for this company.
Legal Structure
| NACE primary | Activiteiten van verpleegkundigen en verloskundigen(86940) |
| Legal form | Private limited company(610) |
| Incorporation | 08-02-2022 |
| Status | Active |
| Postal code | 3650 |
Structure & network
Locations & real estate
Registered office
on the map · from the address registerEstablishment units
1 locationInfermia
since 20222.327.471.250
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area622 m²
Buildings1
Building footprint99 m²
Volume (LiDAR)1,213 m³
Tallest building19.7 m · ±5 fl.
Real-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 73043A0841/00F002 | Flanders | 622 m² | 1 · 99 m² | 19.7 m · 5 fl. |
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Publications
Lifecycle & Insolvency Signals
No insolvency signals in the Belgian State Gazette
Belgisch Staatsblad · acts
2 acts All acts · 2
updated 1 year ago
2024
18-09-2024 1 director appointed, 1 resigning
- QPS Accountants BV, Dagelijks bestuur
- Tiziana Mingolla, Bestuurder
15-05-2024 2 directors appointed
- Tiziana Mingolla, Bestuurder
- QPS Accountants, Dagelijks bestuur
Analysis
Financial profile
5 of 5 axes measured93
/ 100
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Health
100
Profitability
100
Solvency
95
Growth
78
Stability
94
Credit advice
verdict per customer and amountSimilar
Similar companies
Comparable size, same sectorBE 0795.986.750 · Manage
BE 0803.923.627 · Les Bons Villers
BE 1008.088.336 · Couvin
BE 0797.517.865 · Liège
BE 0784.263.509 · Quaregnon
We hold annual accounts for 735 of the 5,948 companies in this sector. 664 of them are within a factor 10 of this company's equity.
Company registry
Company registry (CBE)
Crossroads BankActivities
Verpleegkundige activiteiten86906Activiteiten van verpleegkundigen en verloskundigen86940Overige zakelijke dienstverlening, n.e.g.82990Overige zakelijke dienstverlening, neg82990Overige vormen van onderwijs85599Overige vormen van onderwijs85599
Primary activity highlighted.
Names & trade names
| Legal nameNL | Infermia |
Registered office
Sparrenhuis 27
3650 Dilsen-Stokkem, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.